Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2021

View Archived Issues

Phase II data reported for cabozantinib in type I neurofibromatosis with PNs

BET inhibitors synergize with BCL-2 or HDAC inhibitors in Waldenstrom macroglobulinemia

Grifols to begin clinical evaluation of new COVID-19 treatment

Biohaven presents focused analysis data from phase II/III study of troriluzole in AD

First patient dosed in phase II study of alisporivir in early-stage COVID-19

Eli Lilly initiates phase II study of LY-3462817 in rheumatoid arthritis

Enrollment opens in phase II study of vactosertib plus pembrolizumab in NSCLC

Murine model of SARS-CoV-2 infection developed via mRNA transfection of hACE2

Sobetirome and its prodrug show efficacy in models of EAE

LCP2 is a therapeutic target in lethal sepsis

Shanghai Institute of Materia Medica dicloses new hepatitis B virus inhibitors

New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery

Preclinical data show SENS-401 reduces loss of residual hearing after cochlear implantation

Hangzhou Hertz Pharmaceutical patents casein kinase 1 isoform epsilon inhibitors

DMC recommends start of part 2 of COVA study of Sarconeos in COVID-19

Guangdong Newopp Biopharmaceuticals identifies mutant KRAS inhibitors

New JAK inhibitors synthesized at Guangzhou Innocare Pharma Tech

Phase I trial of LY-CovMab in China completes enrollment

Novel GPC3/CD47 bispecific antibody shows strong antitumor activity in HCC xenografts

HELP is on its way for herpetic stromal keratitis

Transgene gains clearance in France for phase I/IIa study of BT-001 for solid tumors

CRY1 unveiled as a hormone-induced tumorigenic factor in prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...